| |
| |
|
| Insider
Information: |
Quart Barry D |
| Relationship: |
|
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
182,989 |
|
|
Indirect Shares
|
2,500 |
|
|
| Direct
Value |
$597,549 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,489 |
|
|
| Total
Value |
$597,549 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
President and CEO, Dir... |
2012-06-19 |
0 |
2009-05-27 |
2,500 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Chief Executive Office... |
2023-01-13 |
177,989 |
2016-11-04 |
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
|
2014-06-20 |
0 |
2014-06-12 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2022-11-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2014-10-31 |
4 |
A |
$7.50 |
$14,552 |
D/D |
1,941 |
63,796 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-04-30 |
4 |
A |
$7.60 |
$21,896 |
D/D |
2,881 |
45,749 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-06-20 |
4 |
A |
$0.00 |
$0 |
I/I |
600 |
600 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2016-04-29 |
4 |
A |
$18.22 |
$15,253 |
D/D |
837 |
61,679 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2017-04-28 |
4 |
A |
$12.62 |
$21,256 |
D/D |
1,684 |
67,993 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-04-30 |
4 |
A |
$13.22 |
$21,241 |
D/D |
1,607 |
69,600 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-04-30 |
4 |
A |
$18.43 |
$14,853 |
D/D |
806 |
90,081 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2020-04-30 |
4 |
A |
$12.12 |
$14,036 |
D/D |
1,158 |
89,226 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2021-04-30 |
4 |
A |
$13.90 |
$21,249 |
D/D |
1,529 |
96,721 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-04-29 |
4 |
A |
$3.84 |
$5,778 |
D/D |
1,504 |
132,688 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-10-31 |
4 |
A |
$3.27 |
$5,416 |
D/D |
1,655 |
163,441 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2009-08-11 |
4 |
AS |
$19.33 |
$483,130 |
D/D |
(25,000) |
16,511 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2009-12-09 |
4 |
AS |
$14.48 |
$361,993 |
D/D |
(25,000) |
37,015 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2010-02-08 |
4 |
AS |
$14.57 |
$364,268 |
D/D |
(25,000) |
21,515 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2010-05-07 |
4 |
AS |
$21.15 |
$530,062 |
D/D |
(25,000) |
41,515 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2010-08-09 |
4 |
AS |
$20.21 |
$404,268 |
D/D |
(20,000) |
41,858 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2010-12-08 |
4 |
AS |
$21.92 |
$438,392 |
D/D |
(20,000) |
37,202 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2011-02-07 |
4 |
AS |
$26.77 |
$535,352 |
D/D |
(20,000) |
47,202 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
President and CEO |
• • – |
2011-05-09 |
4 |
AS |
$27.20 |
$544,076 |
D/D |
(20,000) |
62,202 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-12 |
4 |
AS |
$83.31 |
$83,310 |
D/D |
(1,000) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-17 |
4 |
AS |
$90.00 |
$90,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-20 |
4 |
AS |
$100.00 |
$137,500 |
D/D |
(1,375) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
AS |
$13.07 |
$130,727 |
D/D |
(10,000) |
42,868 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-03-14 |
4 |
AS |
$24.75 |
$2,475,000 |
D/D |
(100,000) |
67,993 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2018-03-19 |
4 |
AS |
$29.75 |
$2,975,000 |
D/D |
(100,000) |
67,993 |
0 |
- |
|
89 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
